Tempus ECG-Low EF Software
AI software for early identification of low LVEF from ECGs.
Executive Summary
Tempus ECG-Low EF Software is an AI-powered diagnostic aid developed by Tempus AI. It has received U.S. FDA 510(k) clearance, signifying its safety and effectiveness for clinical use. This software is designed to identify patients who may have a low left ventricular ejection fraction (LVEF) by analyzing standard electrocardiogram (ECG) data. The software leverages advanced AI algorithms to process ECG readings, providing clinicians with an early warning system for a condition that can lead to heart failure. By integrating this technology into clinical workflows, Tempus aims to improve the timely diagnosis and management of patients at risk, potentially enabling earlier interventions and better patient outcomes. It is part of Tempus's broader cardiology portfolio, complementing other AI-driven tools like Tempus ECG-AF.
Use Cases
- Early screening for low LVEF in patients undergoing routine ECGs.
- Identifying patients at risk of heart failure for further diagnostic workup.
- Supporting clinicians in making timely decisions for cardiac care.
- Population health management to identify at-risk cohorts.
Features
Visibility
- ECG Waveform Visualization: Interactive display of ECG waveforms alongside AI-generated risk scores for comprehensive review.
- Patient Cohort Management: Tools to manage and track patient cohorts identified with potential low LVEF for follow-up.
Intelligence
- AI-Powered LVEF Prediction: Advanced machine learning models analyze ECG data to predict the likelihood of low LVEF.
- Clinical Decision Support: Provides actionable insights to aid clinicians in identifying at-risk patients for further cardiac evaluation.
Technical Specifications
- Deployment
- SaaS
- API Available
- Yes
AI/ML Stack
- Machine Learning
- Deep Learning
Integrations
- EHR Systems
Security & Compliance
Certifications: HIPAA Compliance
Pricing
- Model
- Subscription-based
- Starting Price
- Contact sales
- Target Customer
- Mid-Market,Enterprise
- Contract Type
- Annual
- Free Trial
- No
About Tempus AI
Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.